Source: iQoncept / Shutterstock
Arrowhead Pharma (NASDAQ:ARWR) just reported results for the second quarter of 2024.
- Arrowhead Pharma reported earnings per share of -$1.02. This was below the analyst estimate for EPS of -16 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/arwr-stock-earnings-arrowhead-pharma-for-q2-of-2024/.
©2024 InvestorPlace Media, LLC